Table 1. Characteristics of male individuals aged 18–55 years in combination with atopy defined as one or more positive skin test (wheal ≥5 mm).
Asthma
|
Unaffected
|
|||
---|---|---|---|---|
Characteristics | Nonatopic | Atopic | Nonatopic | Atopic |
Number | 14 | 17 | 34 | 15 |
Mean age, years | 30.7 | 35.4 | 36.6 | 31.4 |
Median FEV1 (I) [range] | 3.6 [2.1–5.5] | 3.4 [1.7–5.5] | 4.3 [2.7–6.7] | 4.4 [2.9–5.9] |
Median FEV1 % predicted [range] | 83.7 [49–107] | 80.5 [19–155] | 101.5 [77–138] | 99.4 [81–122] |
More than 9% predicted reversible* (%) [n] | 57.1 [8] | 70.5 [12] | 8.8 [3] | 13.2 [2] |
C20 ≤ 32 mg/ml (%) [n] | 85.7 [12] | 100 [17] | 0 | 0 |
Ig E ≥ 120 (%) [n] | 14.3 [2] | 58.8 [10] | 17.6 [6] | 40.0 [6] |
Ig E ≥ 100 (%) [n] | 14.3 [2] | 64.7 [11] | 20.5 [7] | 46.6 [7] |
FEV1, forced expiratory volume in the first second; PC20, provocative concentration of histamine causing 20% drop in FEV1.; 30-sec methods, i.e. healthy is <32 mg/ml.
Reversibility of airway obstruction after inhalation of 400 μg of salbutamol